Click here to view the United Healthcare (UHC) Medical Policy Updates » December 2024 United…
Premera Blue Cross March 2018 Medical Policy Updates
Click here to view the Premera Blue Cross Medical Policy Updates »
March 2018 Medical Policy Updates:
- 01.19 Injectable Clostridial Collagenase for Fibroproliferative Disorders
- 01.501 Wheelchairs (Manual or Motorized)
- 01.519 Colonoscopy
- 01.524 Site of Service: Select Surgical Procedures
- 04.126 Genetic Testing for PALB2 Mutations
- 04.91 General Approach to Genetic Testing
- 04.93 Genetic Cancer Susceptibility Panels Using Next -Generation Sequencing
- 01.519 Nonpharmacologic Treatment of Rosacea
- 01.71 (effective June 1, 2018) Nonpharmacologic Treatment of Rosacea
- 02.507 Coronary Angiography for Known or Suspected Coronary Artery Disease
- 02.507 (effective June 1, 2018) Coronary Angiography for Known or Suspected Coronary Artery Disease
- 04.135 Testing Serum Vitamin D Level
- 04.76 Quantitative Assay for Measurement of HER2 Total Protein Expression and HER2 Dimers
- 01.510 Applied Behavior Analysis (ABA)
- 01.521 Psychiatric Evaluations in Inpatient and Residential Behavioral Health Treatment
- 01.521 Pharmacologic Treatment of Neuropathy, Fibromyalgia and Seizure Disorders
- 01.535 Erythropoiesis-Stimulating Agents
- 01.539 Kalydeco® (ivacaftor) ,Orkambi® (lumacaftor / ivacaftor), and Symdeko™ (tezacaftor / ivacaftor)
- 01.540 Miscellaneous Oncology Drugs
- 01.544 Prostate Cancer Targeted Therapies
- 01.551 Granulocyte Colony-Stimulating Factor (G-CSF) Use in Adult Patients
- 01.560 Excessively High Cost Drug Products with Lower Cost Alternatives
- 01.569 Pharmacotherapy of Type I and Type II Diabetes Mellitus
- 01.571 Soliris® (eculizumab)
- 01.576 (effective June 1, 2018) Drugs for Rare Diseases
- 01.580 Chimeric Antigen Receptor (CAR) T Cell Therapies
- 01.605 Medical Necessity Criteria for Pharmacy Edits
- 01.524 Diagnosis and Treatment of Sacroiliac Joint Pain
- 01.108 Artificial Intervertebral Disc: Cervical Spine
- 01.108 (effective June 1, 2018) Artificial Intervertebral Disc: Cervical Spine
- 01.48 Autologous Chondrocyte Implantation for Focal Articular Cartilage Lesions
- 01.48 (effective June 1, 2018) Autologous Chondrocyte Implantation for Focal Articular Cartilage Lesions
- 01.503 Reduction Mammoplasty for Breast-Related Symptoms
- 01.503 (effective June 1, 2018) Reduction Mammaplasty for Breast-Related Symptoms
- 01.508 Blepharoplasty, Blepharoptosis and Brow Ptosis Surgery
- 01.523 Panniculectomy and Excision of Redundant Skin
- 01.546 Spinal Cord and Dorsal Root Ganglion Stimulation
- 01.546 (effective June 1, 2018) Spinal Cord and Dorsal Root Ganglion Stimulation
- 01.549 Knee Arthroscopy in Adults
- 01.549 (effective June 1, 2018) Knee Arthroscopy in Adults
- 01.550 Knee Arthroplasty in Adults
- 01.551 Lumbar Spine Decompression Surgery: Discectomy, Foraminotomy, Laminotomy, Laminectomy
- 01.551 (effective June 1, 2018) Lumbar Spine Decompression Surgery: Discectomy, Foraminotomy, Laminotomy, Laminectomy
- 01.554 Surgical Treatment of Snoring and Obstructive Sleep Apnea Syndrome
- 01.554 (effective June 1, 2018) Surgical Treatment of Snoring and Obstructive Sleep Apnea Syndrome
- 01.557 Gender Reassignment Surgery
- 01.558 Rhinoplasty
- 01.558 (effective June 1, 2018) Rhinoplasty
- 01.559 Sinus Surgery
- 01.559 (effective June 1, 2018) Sinus Surgery
- 01.560 Anterior Cervical Spine Decompression and Fusion in Adults
- 01.560 (effective June 1, 2018) Anterior Cervical Spine Decompression and Fusion in Adults
- 01.78 Autografts and Allografts in the Treatment of Focal Articular Cartilage Lesions
- 01.78 (effective June 1, 2018) Autografts and Allografts in the Treatment of Focal Articular Cartilage Lesions
- 01.536 Gene Therapy for Inherited Retinal Dystrophy with Luxturna™ (Voretigene Neparvovec)
Click here to view the Premera Blue Cross Medical Policy Updates »
Policy Alerts monitors Commercial and Medicare medical policies for changes. While Payers typically update medical policies annually, there are many reasons why a Payer might review or update a policy. When reviews occur out of cycle, they may go unnoticed. Policy Alerts keeps you informed of upcoming and unexpected coverage changes affecting your product. Quickly understanding the changes Payers make can help you adjust reimbursement strategies impacting your business.
Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on Payer decisions in real-time. Whenever changes occur, email notifications containing a summary of those changes are delivered to your inbox. Clients can access detailed coverage reports and medical policies on the interactive Dashboard portal. Save time and keep focused on the important Payer medical policy reviews and coverage decisions affecting your product!
Policy Alerts takes a client-focused hands-on approach and works hard to provide our customers with helpful insights and actionable analytics over raw data. We understand what our clients need and we are dedicated to making sure we provide timely, accurate and always up-to-date reports that can be used to implement and support a successful reimbursement strategy.
Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.
Related Posts
